FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家银行调整部分加拿大能源基础设施公司的估值

By

-- 加拿大皇家银行资本市场（RBC Capital Markets）周一公布了部分加拿大能源基础设施公司在第一季度财报季前的盈利预期调整。 RBC将Capital Power（CPX.TO）的EBITDA预期从3.6亿加元上调至4亿加元，同时将Keyera（KEY.TO）的EBITDA预期从2.6亿加元下调至2.1亿加元。RBC指出，此举是由于对冲交易的季节性变化及其相关影响。 RBC将Northland Power（NPI.TO）的EBITDA预期从4.05亿加元上调至4.3亿加元，以反映其对欧洲海上风电资源增长的预期。 RBC将TransAlta（TA.TO）的EBITDA预期从2.35亿加元下调至2.17亿加元，原因是该公司的发电量下降。 加拿大皇家银行(RBC)将Emera (EMA.TO)的每股收益预期从1.17美元上调至1.20美元，主要原因是坦帕电力公司(Tampa Electric)的天气状况更为有利，以及价格波动高于预期。 加拿大皇家银行将Enbridge (ENB.TO)的折现现金流预期从1.75美元下调至1.72美元，以反映加拿大能源监管机构(CER)的监管决定对其MTS财务回报计算的预期影响。 加拿大皇家银行将Gibson Energy (GEI.TO)的EBITDA预期从1.54亿美元下调至1.49亿美元，主要原因是观察到的航运活动减少。 加拿大皇家银行将Hydro One (H.TO)的每股收益预期从0.58美元上调至0.64美元，原因是安大略省60分钟高峰需求和费率基数增长高于预期。 RBC 将 Pembina (PPL.TO) 的 EBITDA 预期从 10.63 亿美元上调至 10.97 亿美元，主要原因是压裂业务范围的改善有利于市场营销。

Price: $66.88, Change: $-0.37, Percent Change: -0.55%

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP